Drug intelligence / Profile preview

LT-0002

Development stage
Preclinical
Lead developer
LTT Bio-Pharma
Modality
Recombinant Proteins and Enzymes, Drug Delivery Systems
01

Overview

LT-0002 is a preclinical-stage drug delivery system (DDS) platform developed by LTT Bio-Pharma. It utilizes a proprietary "Protein-technicization technology" designed to enhance the delivery, stability, and therapeutic profile of biologic drugs, specifically proteins. By modifying the structural or chemical properties of proteins, the technology aims to overcome common pharmacological hurdles such as rapid degradation or poor bioavailability. While the platform is part of LTT Bio-Pharma's active R&D pipeline, specific target indications or lead protein candidates associated with the LT-0002 designation have not been publicly specified in detail beyond its classification as a DDS for biologics.

Other names
LT-0002-LTT Bio-Pharma-Biologics-DDSLT0002-LTT Bio-Pharma-Biologics-DDSLT 0002-LTT Bio-Pharma-Biologics-DDSProtein-technicization technology

Beyond the preview

Go deeper on LT-0002.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LT-0002.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call